首页> 外文OA文献 >Cancer cell-specific internalizing ligands from phage displayed β-lactamase-peptide fusion libraries
【2h】

Cancer cell-specific internalizing ligands from phage displayed β-lactamase-peptide fusion libraries

机译:来自噬菌体的癌细胞特异性内在配体展示了β-内酰胺酶-肽融合文库

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study was focused on identifying cancer cell-specific internalizing ligands using a new kind of phage display library in which the linear or cysteine-constrained random peptides were at amino-terminus fusion to catalytically active P99 β-lactamase molecules. The size and quality of libraries were comparable to other reported phage display systems. Several cancer cell-specific binding and internalizing β-lactamase-peptide fusion ligands were isolated by selecting these libraries on the live BT-474 human breast cancer cells. The identified ligands shared several significant motifs, which showed their selectivity and possible binding to some common cancer cell targets. The β-lactamase fusion made the whole process of clone screening efficient and simple. The ligands selected from such libraries do not require peptide synthesis and modifications, and can be used directly for applications that require ligand tracking. In addition, the selected β-lactamase-peptide ligands have a potential for their direct use in targeted enzyme prodrug therapy. The cancer-specific peptides can also be adopted for other kinds of targeted delivery protocols requiring cell-specific affinity reagents. This is first report on the selection of cell-internalized enzyme conjugates using phage display technology, which opens the possibility for new fusion libraries with other relevant enzymes.
机译:本研究致力于使用新型噬菌体展示文库鉴定癌细胞特异性内在配体,其中线性或半胱氨酸约束的随机肽在氨基末端与催化活性的P99β-内酰胺酶分子融合。文库的大小和质量与其他报道的噬菌体展示系统相当。通过在活的BT-474人乳腺癌细胞上选择这些文库,可以分离出几种癌细胞特异性结合和内在化的β-内酰胺酶-肽融合配体。鉴定出的配体共有几个重要的基序,这些基序显示出它们的选择性以及与某些常见癌细胞靶标的可能结合。 β-内酰胺酶融合使克隆筛选的整个过程高效,简单。从此类文库中选择的配体不需要肽合成和修饰,并且可以直接用于需要配体追踪的应用。另外,所选的β-内酰胺酶-肽配体具有直接用于靶向酶前药治疗的潜力。癌症特异性肽还可以用于需要细胞特异性亲和试剂的其他种类的靶向递送方案。这是有关使用噬菌体展示技术选择细胞内在化酶结合物的首次报道,这为与其他相关酶建立新融合文库的可能性提供了可能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号